Novartis Sues to Block Maryland’s New Drug Discount Law
Novartis has filed a lawsuit to block a Maryland law requiring drugmakers to offer discounts on drugs through third-party pharmacies contracting with hospitals and clinics.
Dell Technologies Shares Dip Despite Beating Q1 Expectations: What You Need To Know
Dell Technologies (NYSE: DELL) shares experienced a decline Friday afternoon despite reporting better-than-expected Q1 financial results.
Best Buy To Stabilize Despite A Soft Q1, Analysts Say
Goldman Sachs analyst Kate McShane noted BBY reported better-than-expected Q1 results and provided guidance that still suggests a potential top-line recovery in the second half of the year.
Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes
Novo Nordisk has filed lawsuits against nine additional U.S. medical spas, wellness clinics, and pharmacies for selling impure or falsely labeled semaglutide products.
Carl Icahn Builds ‘Sizable’ Position In Caesars Entertainment
Caesars Entertainment shares are trading higher Friday after reports indicate activist-investor Carl Icahn has amassed a sizable stake in the company.
Foot Locker Shows It’s Headed In The Right Direction With Its Turnaround Plan
On Thursday, Foot Locker (NYSE: FL) showed its turnaround plan is working as it posted better-than-expected comparable sales, with shares surging 15% upon the release of its May quarter report. Although the footwear retailer is still in the black, its financials are declining at a slower rate.
Pfizer Highlights ‘Unprecedented’ 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer
Pfizer's Phase 3 CROWN trial results show Lorbrena significantly outperforms Xalkori in treating ALK-positive advanced NSCLC.
What’s Going On With Snowflake Stock?
Snowflake lowered its expectations for gross margin and its adjusted operating margin for the second quarter which executives explained is a result of large expenses required to build the necessary infrastructure for AI.
Decoding 6 Analyst Evaluations For CareDx
Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on CareDx (NASDAQ:CDNA)…
Beyond The Numbers: 4 Analysts Discuss Viasat Stock
In the last three months, 4 analysts have published ratings on Viasat (NASDAQ:VSAT), offering a diverse range of…